Restart Life Sciences Announces Closing First Tranche of Financing

Core Viewpoint - Restart Life Sciences Corp. has successfully closed the first tranche of its non-brokered private placement, raising a total of CDN$500,000 [1]. Group 1: Private Placement Details - The company issued 5,000,000 units at a price of CDN$0.10 per unit, with each unit consisting of one common share and one transferable common share purchase warrant [2]. - The warrants allow holders to purchase one additional common share for one year at a price of CAD $0.10 per share [2]. Group 2: Finder's Fees and Warrants - In connection with the placement, the company paid cash finder's fees totaling CAD $16,800 and issued 60,000 non-transferable finder warrants [3]. - Each finder warrant entitles the holder to purchase one common share for one year at a price of CAD $0.10 per share [3]. Group 3: Use of Proceeds - The proceeds from the offering will be used for health food trials, potential acquisitions, and general working capital [4]. - All securities issued under the placement are subject to a hold period of four months and one day, expiring on April 6, 2026 [4]. Group 4: Company Overview - Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the Canadian Securities Exchange [5].